MedTrace Logo

Gel-One Treatment in Knee Osteoarthritis

NCT01934218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 814

Last updated 2023-03-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Gel-One demonstrates a superior effectiveness in osteoarthritis (OA) knee pain compared with phosphate buffered saline (PBS) injections.

Conditions

  • Osteoarthritis Knee

Interventions

DEVICE

Gel-One

DEVICE

PBS

Sponsors & Collaborators

  • Zimmer Biomet

    collaborator INDUSTRY

  • Seikagaku Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01934218 on ClinicalTrials.gov